Skip to main content

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.




) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 0.5%. By the end of trading, Allergan rose $1.31 (1.2%) to $109.93 on light volume. Throughout the day, 1,149,203 shares of Allergan exchanged hands as compared to its average daily volume of 2,164,600 shares. The stock ranged in a price between $108.31-$109.93 after having opened the day at $108.61 as compared to the previous trading day's close of $108.62. Other companies within the Health Care sector that increased today were:

Coronado Biosciences



), up 26.7%,

Inovio Pharmaceuticals



), up 20.2%,

Apricus Biosciences



TheStreet Recommends

), up 16.6% and




), up 15.3%.

Allergan, Inc. operates as a multi-specialty healthcare company primarily in the United States, Europe, Latin America, and the Asia Pacific. Allergan has a market cap of $32.3 billion and is part of the drugs industry. Shares are up 18.4% year to date as of the close of trading on Tuesday. Currently there are 10 analysts that rate Allergan a buy, no analysts rate it a sell, and 9 rate it a hold.

TheStreet Ratings rates


as a


. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, increase in net income and notable return on equity. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.

On the negative front,

Mast Therapeutics



), down 39.1%,

Oramed Pharmaceuticals



), down 21.3%,

Heat Biologics



), down 7.4% and

Hemispherx Biopharma



), down 6.4% , were all laggards within the health care sector with

ACADIA Pharmaceuticals



) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR



) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care




3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.